| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.04 |